GLP-2
<p></p> <p>GLP-2 is a <strong>once‑weekly, subcutaneous injectable medication</strong> used for <strong>type 2 diabetes</strong>, <strong>chronic weight management</strong>, and <strong>obesity‑related obstructive sleep apnea (OSA)</strong>. It works by activating <strong>both GIP and GLP‑1 receptors</strong>, offering dual‑pathway metabolic benefits.</p> <p> </p> <p></p>
Details
<p></p> <p>GLP-2 is a <strong>once‑weekly, subcutaneous injectable medication</strong> used for <strong>type 2 diabetes</strong>, <strong>chronic weight management</strong>, and <strong>obesity‑related obstructive sleep apnea (OSA)</strong>. It works by activating <strong>both GIP and GLP‑1 receptors</strong>, offering dual‑pathway metabolic benefits.</p> <p> </p> <p></p>